| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Insidertrades | Knock-outs | myHome | |
| Orderbuch | Realtime Stuttgart | RSS Feed | im Forum | Fonds | Senden/Drucken | |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
Ligand Pharmaceuticals zu myNews hinzufügen Was ist das?
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report second quarter 2011 financial results on Monday, August 8, 2011. Ligand’s President and CEO, John L. Higgins, Executive Vice President and COO, Matt Foehr and Vice President of Finance and CFO, John Sharp will host the conference call.
Second Quarter Earnings Call
| What: | Ligand Pharmaceuticals conference call to discuss financial results and provide general business updates. | ||
| When: | Monday, August 8, 2011 | ||
| Time: | 1:30 p.m. Pacific time (4:30 p.m. Eastern time) | ||
| Webcast: |
Conference call and replay accessible at www.ligand.com. |
||
| Conference Call: | (877) 407-4019, passcode: Ligand | ||
| (201) 689-8337 outside the U.S. | |||
| Replay: | (877) 660-6853, Account #: 361 passcode: 376512 | ||
| (201) 612-7415 outside the U.S. | |||
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company with a business model of developing or acquiring royalty revenue-generating assets and coupling them to a lean corporate cost structure with the goal of producing sustained profitability. By diversifying the portfolio of assets across numerous technology types, therapeutic areas, drug targets and industry partners, we offer an opportunity to invest in the increasingly complicated and unpredictable pharmaceutical industry. In comparison to our industry peers, we believe Ligand has assembled one of the largest and most diversified asset portfolios in the industry with significant revenue-generating potential. These therapies address the unmet medical needs of patients for a broad spectrum of diseases including hepatitis C, muscle wasting, Alzheimer's disease, dyslipidemia, diabetes, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand has established alliances with several of the world's leading pharmaceutical companies including GlaxoSmithKline, Merck, The Medicines Company, Pfizer, Bristol-Myers Squibb and AstraZeneca. For more information, please visit www.ligand.com. Follow Ligand on Twitter @Ligand_LGND.
| Geben Sie jetzt einen Kommentar zu diesem Artikel ab. |
08.02.12 | Ligand Pharmaceuticals Crushes Estimates (EN, MotleyFool) |
14.11.11 | Edison Investment Research Expects Growth for Ligand Pharmaceuticals (EN, Benzinga earnings) |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
16.04.12 | Ligand to Report First Quarter Results on May 2nd (Businesswire) |
05.03.12 | Ligand to Present at the 24th Annual Roth Conference on March 12 (Businesswire) |
21.02.12 | Ligand to Present at the Citi Global Health Care Conference on February 28th (Businesswire) |
21.02.12 | Ligand Licenses DARA Program to Retrophin (Businesswire) |
09.02.12 | Ligand to Present at the BIO CEO and Investor Conference on February 13 (Businesswire) |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
16.04.12 | Ligand to Report First Quarter Results on May 2nd (Businesswire) |
05.03.12 | Ligand to Present at the 24th Annual Roth Conference on March 12 (Businesswire) |
21.02.12 | Ligand to Present at the Citi Global Health Care Conference on February 28th (Businesswire) |
21.02.12 | Ligand Licenses DARA Program to Retrophin (Businesswire) |
09.02.12 | Ligand to Present at the BIO CEO and Investor Conference on February 13 (Businesswire) |
| Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv |
08.02.12 | Ligand Pharmaceuticals Crushes Estimates (EN, MotleyFool) |
14.11.11 | Edison Investment Research Expects Growth for Ligand Pharmaceuticals (EN, Benzinga earnings) |
| Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
16.04.12 | Ligand to Report First Quarter Results on May 2nd (Businesswire) |
05.03.12 | Ligand to Present at the 24th Annual Roth Conference on March 12 (Businesswire) |
21.02.12 | Ligand to Present at the Citi Global Health Care Conference on February 28th (Businesswire) |
21.02.12 | Ligand Licenses DARA Program to Retrophin (Businesswire) |
09.02.12 | Ligand to Present at the BIO CEO and Investor Conference on February 13 (Businesswire) |
| Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
16.04.12 | Ligand to Report First Quarter Results on May 2nd (Businesswire) |
05.03.12 | Ligand to Present at the 24th Annual Roth Conference on March 12 (Businesswire) |
21.02.12 | Ligand to Present at the Citi Global Health Care Conference on February 28th (Businesswire) |
21.02.12 | Ligand Licenses DARA Program to Retrophin (Businesswire) |
09.02.12 | Ligand to Present at the BIO CEO and Investor Conference on February 13 (Businesswire) |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
07.05.12 | Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 (Businesswire) |
14.05.12 | Ligand to Present at the Jefferies 2011 Global Healthcare Conference on June 4 (Businesswire) |
02.05.12 | Ligand Pharmaceuticals Reports First Quarter Results (Businesswire) |
Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden
| 06.07.10 | Ligand Pharmaceuticals Talfahrt sollte vorbei sein | Global Biotech Investing | |
| 05.08.09 | Ligand Pharmaceuticals Downgrade | Merriman Curhan Ford & Co | |
| 22.01.09 | Ligand Pharmaceuticals Ersteinschätzung | Oppenheimer & Co. Inc. | |
| 27.11.08 | Ligand Pharmaceuticals market outperform | Rodman & Renshaw, LLC | |
| 29.05.08 | Ligand Pharmaceuticals neues Kursziel | Susquehanna Financial Group, LLLP |
| 06.07.10 | Ligand Pharmaceuticals Talfahrt sollte vorbei sein | Global Biotech Investing | |
| 22.01.09 | Ligand Pharmaceuticals Ersteinschätzung | Oppenheimer & Co. Inc. | |
| 27.11.08 | Ligand Pharmaceuticals market outperform | Rodman & Renshaw, LLC | |
| 29.05.08 | Ligand Pharmaceuticals neues Kursziel | Susquehanna Financial Group, LLLP | |
| 07.12.07 | Ligand Pharmaceuticals positive | Susquehanna Financial Group, LLLP |
| 05.08.09 | Ligand Pharmaceuticals Downgrade | Merriman Curhan Ford & Co | |
| 21.03.06 | Update Ligand Pharmaceuticals Inc.: Neutral | First Albany | |
| 17.03.06 | Ligand Pharmaceuticals Downgrade | First Albany | |
| 19.01.06 | Ligand Pharmaceuticals Upgrade | Evern Securities | |
| 18.01.06 | Update Ligand Pharmaceuticals Inc.: Market Perform | Friedman, Billings Ramsey & Co |
| Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
| Keine Nachrichten gefunden. |
| Keine Nachrichten gefunden. |
| 21.05.2012 | Die wertvollsten Fußball-Klubs der Welt |
| 24.04.2012 | Die besten Chefs der Welt |
| 23.04.2012 | Mit diesen Autos greifen die Deutschen in China an |
| 12.04.2012 | Welche DAX-Konzerne ihre Anleger überschütten |
| 10.05.2012 | Verträumte Finca auf Mallorca |
